Trial site

Universitaetsklinikum Koeln

Köln, 50937, GermanyUniversity Hospital Cologne

2closed trials

Part of

University Hospital Cologne

“Universitaetsklinikum Koeln” is one of the names under which trial registries list University Hospital Cologne. Together they cover 40 sites; the figures below count all of them.

479trials across all its sites
327of them running
40registry sites and names
40,559publications (OpenAlex)

Type (ROR): Healthcare
Website: uk-koeln.de
Publishes most on: Lung cancer
Parkinson disease
Hodgkin lymphoma
Chronic lymphocytic leukaemia
Glaucoma
Dystonia

See all 479 trials at University Hospital Cologne

Institution data from ROR and OpenAlex, trial counts from the trial registries.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions: Macular degeneration1 trial
Obesity1 trial
Type 2 diabetes1 trial
Phase: Phase 32 trials
Status: Completed2 trials
Lead sponsor: Apellis Pharmaceuticals, Inc.1 trial
Eli Lilly and Company1 trial

Researchers at University Hospital Cologne

Linked to University Hospital Cologne in public sources, not necessarily to the trials at this site.

Reinhard Büttner

Closed trials

Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
NCT05872620· Phase 3· Eli Lilly and Company· Source
Completed
An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD
NCT04770545· Phase 3· Apellis Pharmaceuticals, Inc.· Source

Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026

Report an error